Clearside Biomedical, Inc. Financial Summary

Complete Filing Data

Clearside Biomedical, Inc. reported Net Income Loss of -$34.35 million for FY2024.

All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Clearside Biomedical, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.

Income Statement

Annual (10-K / 20-F)

Metric \ Fiscal YearFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Net Income *-$34.4M-$32.5M-$32.9M$376.0K-$18.2M-$30.8M-$82.8M-$59.0M-$25.9M-$17.6M-$10.2M
Operating Expenses$33.1M$31.6M$30.2M$25.8M$32.5M$83.0M$58.8M$25.7M$17.3M$9.8M
Operating Income Loss-$28.9M-$24.8M-$30.3M-$627.0K-$17.9M-$30.3M-$82.9M-$58.4M-$25.2M-$17.3M-$9.8M
Research And Development Expense$18.6M$20.8M$19.6M$18.5M$15.1M$15.7M$68.3M$49.1M$19.5M$10.8M$6.7M
General And Administrative Expense$11.8M$11.9M$11.8M$11.7M$10.8M$16.8M$14.7M$9.7M$6.3M$6.6M$3.1M
Revenue From Contract With Customer Excluding Assessed Tax$1.7M$8.2M$1.3M$29.6M$7.9M$2.2M$30.0K$345.0K$520.0K
Nonoperating Income Expense-$275.0K-$466.0K$127.0K-$567.0K-$684.0K-$322.0K-$366.0K
Other Nonoperating Income$2.8M$0.00$0.00$1.0M$0.00$0.00
Non Cash Interest Expense On Liability Related To Sales Of Future Royalties$9.8M$9.4M$3.3M$0.00$0.00
Deferred Revenue Current$0.00$75.0K$205.0K$0.00$5.0M$5.0M
Comprehensive Income Net Of Tax-$30.8M-$82.8M-$59.0M-$25.9M-$17.6M-$10.2M
Cost Of Goods And Services Sold$149.0K$355.0K$204.0K$0.00
Non Cash Interest Expense On Liability Related To The Sales Of Future Royalites$9.4M$3.3M$0.00$0.00

Quarterly (10-Q, single quarters)

Metric \ QuarterQ3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021Q1 2021Q3 2020Q2 2020Q1 2020Q4 2019Q3 2019Q2 2019Q1 2019Q4 2018Q3 2018Q2 2018Q1 2018Q4 2017Q3 2017Q2 2017Q1 2017Q4 2016Q3 2016Q2 2016Q1 2016Q4 2015Q3 2015Q2 2015Q1 2015
Net Income *-$6.0M-$4.5M-$8.2M-$7.7M-$7.6M-$11.8M-$9.3M-$9.1M-$9.3M-$7.8M-$7.8M-$7.6M-$4.9M-$6.1M-$7.4M-$2.4M-$5.8M-$2.9M-$3.1M-$6.5M-$5.7M-$15.4M-$21.6M-$23.9M-$20.7M-$16.6M-$16.5M-$18.3M-$13.8M-$10.4M-$9.7M-$5.6M-$5.1M-$5.4M-$5.2M-$3.5M-$5.3M-$3.8M
Operating Expenses$8.4M$7.9M$8.3M$7.6M$7.0M$8.2M$8.0M$8.0M$6.9M$8.4M$5.9M$5.9M$6.9M$5.0M$6.5M$5.7M$15.4M$21.7M$24.0M$20.9M$16.5M$16.4M$18.3M$13.8M$10.3M$9.4M$5.3M$5.2M$5.9M$5.0M$3.4M$5.2M$3.8M
Operating Income Loss-$7.0M-$3.6M-$5.2M-$5.9M-$7.6M-$8.2M-$7.1M-$7.3M-$7.6M-$6.7M-$7.8M-$7.6M-$4.9M-$6.1M-$8.3M-$2.4M-$5.6M-$2.8M-$6.4M-$5.6M-$15.3M-$24.0M-$20.9M-$16.5M-$18.2M-$13.6M-$10.3M-$5.3M-$5.2M-$5.4M-$3.4M-$5.2M
Research And Development Expense$2.9M$1.6M$4.5M$4.1M$4.6M$5.6M$5.1M$4.9M$4.5M$4.6M$5.4M$4.5M$5.1M$4.1M$5.5M$3.5M$3.3M$3.8M$2.7M$658.0K$11.0M$20.1M$17.3M$13.4M$16.1M$11.5M$7.6M$3.7M$4.2M$4.6M$2.3M$2.1M
General And Administrative Expense$4.3M$2.5M$2.8M$2.8M$3.1M$2.8M$2.6M$3.1M$3.2M$2.4M$2.8M$3.5M$2.8M$2.8M$2.9M$2.4M$2.6M$3.1M$3.8M$5.0M$4.4M$3.9M$3.6M$3.1M$2.3M$2.3M$2.7M$1.6M$970.0K$1.3M$1.1M$3.0M
Revenue From Contract With Customer Excluding Assessed Tax$201.0K$492.0K$2.3M$1.0M$90.0K$230.0K$859.0K$1.0M$4.0K$266.0K$384.0K$347.0K$3.1M$780.0K$34.0K$3.4M$354.0K$4.1M$141.0K$45.0K$45.0K$155.0K$130.0K
Nonoperating Income Expense-$1.0K-$197.0K-$75.0K-$168.0K-$117.0K-$98.0K$84.0K$203.0K-$154.0K-$143.0K-$135.0K-$117.0K-$339.0K$76.0K-$92.0K-$101.0K-$67.0K
Other Nonoperating Income$365.0K$1.9M$0.00$0.00$492.0K$194.0K$24.0K$2.0K$2.0K$1.0K$998.0K$0.00$0.00$0.00
Non Cash Interest Expense On Liability Related To Sales Of Future Royalties$2.6M$2.8M$2.7M$2.5M$2.3M$2.4M$2.6M$2.3M$2.2M$1.3M$0.00$0.00$0.00
Deferred Revenue Current$0.00$225.0K$150.0K$0.00$355.0K$280.0K$113.0K$198.0K$5.0M$5.0M$5.0M$5.0M$5.0M$5.1M$20.0K
Comprehensive Income Net Of Tax-$23.9M-$20.7M-$16.6M-$18.3M-$13.8M-$10.4M-$5.7M-$5.1M-$5.4M-$3.5M
Cost Of Goods And Services Sold$0.00$0.00$248.0K$0.00$0.00$0.00$142.0K$213.0K$0.00$0.00
Non Cash Interest Expense On Liability Related To The Sales Of Future Royalites$2.7M$2.4M$2.2M$0.00

Balance Sheet

Annual (10-K / 20-F)

Metric \ Fiscal YearFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014FY2013
Stockholders Equity$10.6M$38.0M$8.8M$11.2M$23.6M$21.4M$71.7M-$36.7M-$19.2M-$10.7M
Cash And Cash Equivalents At Carrying Value$28.9M$48.3M$30.4M$17.3M$22.6M$8.0M$9.2M$34.8M$20.3M$8.3M$1.9M
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations$48.4M$30.7M$17.6M$23.0M$8.4M$9.6M$35.2M
Retained Earnings Accumulated Deficit-$320.9M-$288.4M-$255.5M-$255.9M-$237.7M-$206.9M-$124.2M-$65.2M-$39.4M
Property Plant And Equipment Net$3.0M$755.0K$238.0K$416.0K$541.0K$790.0K$885.0K$94.0K$156.0K
Liabilities Current$6.8M$5.8M$4.6M$9.9M$10.9M$10.5M$13.5M$5.4M$5.2M
Liabilities And Stockholders Equity$34.0M$51.3M$42.9M$19.3M$26.8M$44.1M$40.5M$84.8M$21.1M
Liabilities$49.9M$40.7M$4.9M$10.6M$15.6M$20.5M$19.1M$13.2M$10.4M
Common Stock Value$63.0K$61.0K$60.0K$52.0K$44.0K$32.0K$25.0K$25.0K$3.0K
Assets Current$30.1M$49.4M$42.1M$18.1M$25.2M$42.9M$39.2M$84.3M$20.5M
Assets$34.0M$51.3M$42.9M$19.3M$26.8M$44.1M$40.5M$84.8M$21.1M
Accrued Liabilities Current$4.2M$4.2M$3.3M$1.6M$2.9M$2.9M$4.7M$2.8M$2.0M
Accounts Payable Current$2.2M$1.1M$941.0K$2.0M$1.3M$6.9M$5.4M$2.6M$1.5M
Other Assets Current$14.0K$439.0K$779.0K$109.0K$1.5M$17.0K$116.0K$290.0K$40.0K
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect-$8.9M-$19.5M$17.7M$13.0M-$5.3M$14.6M-$1.2M-$25.6M$14.5M
Deferred Finance Costs Own Share Lending Arrangement Issuance Costs Amortization Expense1$0.00$0.00$129.0K$67.0K$112.0K$212.0K$108.0K$60.0K$277.0K
Restricted Cash And Cash Equivalents Noncurrent$30.0K$160.0K$260.0K$360.0K$360.0K$360.0K$360.0K
Other Assets Noncurrent$30.0K$30.0K$26.0K$47.0K$42.0K$7.0K
Operating Lease Right Of Use Asset$869.0K$1.1M$369.0K$528.0K$656.0K
Operating Lease Liability Noncurrent$649.0K$936.0K$288.0K$616.0K$897.0K
Operating Lease Liability Current$364.0K$349.0K$387.0K$373.0K$360.0K
Restricted Cash$0.00$0.00$160.0K$260.0K$360.0K$360.0K$360.0K$360.0K
Long Term Debt Noncurrent$3.8M$9.4M$4.8M$7.6M$4.2M
Accretion Amortization Of Discounts And Premiums Investments$0.00$0.00$115.0K$748.0K$31.0K$43.0K
Long Term Debt Current$991.0K$1.3M$556.0K$3.2M$1.7M
Repayments Of Long Term Debt$0.00$0.00$5.3M$5.0M$8.3M$6.3M$125.0K
Preferred Stock Value$0.00$0.00$0.00
Liabilities Related To The Sales Of Future Royalties$34.0M$0.00

Quarterly (10-Q, single quarters)

Metric \ QuarterQ3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021Q1 2021Q3 2020Q2 2020Q1 2020Q3 2019Q2 2019Q1 2019Q3 2018Q2 2018Q1 2018Q3 2017Q2 2017Q1 2017Q3 2016Q2 2016Q1 2016Q3 2015Q2 2015
Stockholders Equity-$54.0M-$48.7M-$45.9M-$38.9M-$34.8M-$28.3M-$21.8M-$15.9M-$12.8M-$5.0M$2.7M$18.5M$25.2M$31.7M$17.8M$19.3M$17.0M$8.1M$7.3M$10.4M$9.8M$12.9M$16.1M$44.1M$66.7M$85.9M$36.9M$54.3M$67.2M$46.9M$45.9M
Cash And Cash Equivalents At Carrying Value$6.8M$9.4M$13.6M$20.0M$13.9M$18.2M$35.4M$28.8M$35.0M$41.4M$53.4M$29.0M$34.4M$25.2M$26.4M$26.1M$14.8M$15.1M$20.9M$22.6M$26.2M$33.0M$15.8M$35.2M$84.8M$16.3M$16.7M$23.0M$36.9M$55.3M$15.9M$4.2M$7.3M
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations$6.8M$9.4M$13.6M$20.0M$13.9M$18.2M$35.4M$28.9M$28.8M$35.0M$41.4M$53.5M$29.2M$34.6M$25.5M$26.7M$26.5M$15.2M$15.4M$21.3M$22.9M$26.5M$33.3M$16.2M$35.5M
Retained Earnings Accumulated Deficit-$374.0M-$368.0M-$363.5M-$355.3M-$348.0M-$340.3M-$332.7M-$316.1M-$306.8M-$297.7M-$278.8M-$270.9M-$263.1M-$274.2M-$269.3M-$263.2M-$248.8M-$246.3M-$240.6M-$234.6M-$228.0M-$222.3M-$185.2M-$161.4M-$140.7M-$107.7M-$89.4M-$75.6M-$55.6M-$49.9M
Property Plant And Equipment Net$3.0M$3.1M$3.1M$3.2M$3.4M$3.4M$3.2M$2.6M$2.1M$1.0M$437.0K$321.0K$301.0K$283.0K$327.0K$371.0K$460.0K$506.0K$551.0K$655.0K$708.0K$755.0K$778.0K$791.0K$838.0K$932.0K$963.0K$1.0M$110.0K$124.0K
Liabilities Current$2.8M$3.0M$5.0M$4.8M$5.6M$5.9M$6.0M$5.8M$5.3M$5.0M$5.2M$5.4M$4.2M$9.2M$8.8M$10.3M$8.2M$9.2M$13.8M$10.8M$8.0M$11.7M$14.9M$10.9M$13.8M$11.7M$7.1M$7.2M$2.9M$6.7M
Liabilities And Stockholders Equity$11.6M$15.3M$19.7M$25.1M$29.2M$33.9M$40.1M$34.4M$39.2M$44.7M$55.7M$30.7M$36.1M$27.4M$28.6M$27.8M$17.4M$17.7M$25.0M$25.9M$29.9M$37.5M$69.4M$88.0M$104.5M$54.9M$68.4M$82.0M$57.8M$56.2M
Liabilities$65.6M$64.1M$65.6M$64.0M$64.0M$62.2M$62.0M$47.3M$44.2M$42.0M$37.1M$5.5M$4.4M$9.5M$9.3M$10.8M$9.3M$10.5M$14.6M$16.1M$17.0M$21.4M$25.3M$21.3M$18.5M$18.0M$14.1M$14.8M$10.8M$10.3M
Common Stock Value$78.0K$78.0K$77.0K$77.0K$75.0K$74.0K$74.0K$62.0K$62.0K$61.0K$60.0K$60.0K$60.0K$60.0K$59.0K$58.0K$48.0K$46.0K$45.0K$41.0K$38.0K$37.0K$32.0K$32.0K$32.0K$25.0K$25.0K$25.0K$21.0K$20.0K
Assets Current$8.3M$11.8M$16.0M$21.3M$25.1M$29.8M$36.1M$30.8M$36.1M$42.6M$54.9M$30.0M$35.3M$26.5M$27.7M$26.7M$16.0M$16.3M$23.5M$24.0M$27.9M$35.5M$68.2M$86.8M$103.2M$53.5M$67.0M$80.5M$57.7M$56.0M
Assets$11.6M$15.3M$19.7M$25.1M$29.2M$33.9M$40.1M$34.4M$39.2M$44.7M$55.7M$30.7M$36.1M$27.4M$28.6M$27.8M$17.4M$17.7M$25.0M$25.9M$29.9M$37.5M$69.4M$88.0M$104.5M$54.9M$68.4M$82.0M$57.8M$56.2M
Accrued Liabilities Current$1.6M$1.5M$2.7M$3.0M$2.9M$3.7M$4.1M$3.6M$2.7M$2.8M$2.9M$2.4M$2.2M$3.0M$2.2M$2.6M$1.3M$1.6M$1.5M$2.7M$2.9M$4.5M$2.7M$2.4M$3.7M$4.0M$1.6M$1.5M$1.6M$1.9M
Accounts Payable Current$796.0K$1.1M$1.9M$1.5M$2.4M$1.6M$1.4M$1.9M$1.9M$1.6M$1.7M$2.6M$1.4M$776.0K$1.2M$2.3M$909.0K$1.7M$1.6M$1.4M$2.2M$5.3M$11.9M$8.4M$6.7M$5.1M$3.7M$4.7M$1.3M$2.4M
Other Assets Current$0.00$13.0K$77.0K$13.0K$13.0K$44.0K$193.0K$14.0K$305.0K$386.0K$311.0K$394.0K$339.0K$100.0K$880.0K$142.0K$9.0K$611.0K$1.7M$27.0K$60.0K$33.0K$6.0K$141.0K$292.0K$522.0K$73.0K$17.0K
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect-$6.4M$6.4M-$7.0M$3.9M$8.9M-$1.7M$24.9M$75.6M-$11.8M
Deferred Finance Costs Own Share Lending Arrangement Issuance Costs Amortization Expense1$21.0K$15.0K$49.0K$53.0K$21.0K
Restricted Cash And Cash Equivalents Noncurrent$160.0K$160.0K$160.0K$160.0K$160.0K$260.0K$360.0K$360.0K$360.0K$360.0K$360.0K$360.0K$360.0K$360.0K$360.0K$360.0K$360.0K$360.0K
Other Assets Noncurrent$30.0K$30.0K$30.0K$30.0K$30.0K$30.0K$30.0K$30.0K$30.0K$30.0K$26.0K$26.0K$54.0K$44.0K$35.0K$103.0K$90.0K$104.0K$7.0K$7.0K
Operating Lease Right Of Use Asset$376.0K$452.0K$525.0K$597.0K$667.0K$736.0K$803.0K$933.0K$996.0K$1.1M$226.0K$276.0K$324.0K$412.0K$452.0K$491.0K$563.0K$595.0K$627.0K$806.0K$867.0K$925.0K
Operating Lease Liability Noncurrent$62.0K$152.0K$241.0K$328.0K$412.0K$493.0K$572.0K$724.0K$796.0K$867.0K$0.00$105.0K$200.0K$374.0K$458.0K$539.0K$689.0K$762.0K$832.0K$961.0K$1.0M$1.1M
Operating Lease Liability Current$384.0K$381.0K$378.0K$375.0K$373.0K$370.0K$367.0K$362.0K$359.0K$356.0K$407.0K$395.0K$391.0K$384.0K$380.0K$377.0K$370.0K$366.0K$363.0K$483.0K$504.0K$499.0K
Restricted Cash$0.00$0.00$0.00$160.0K$160.0K$260.0K$260.0K$260.0K$360.0K$360.0K$360.0K$360.0K$360.0K$360.0K$360.0K$360.0K$360.0K$360.0K
Long Term Debt Noncurrent$385.0K$496.0K$4.3M$7.9M$8.6M$9.9M$9.8M$4.1M$5.5M$6.2M$6.9M$7.5M$3.3M
Accretion Amortization Of Discounts And Premiums Investments$103.0K$43.0K-$18.0K
Long Term Debt Current$606.0K$495.0K$5.2M$5.8M$2.2M$1.4M$3.2M$2.4M$1.6M$800.0K$2.4M
Repayments Of Long Term Debt$800.0K
Preferred Stock Value$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Liabilities Related To The Sales Of Future Royalties$61.2M$55.7M$53.4M$51.8M$49.2M$46.7M$44.4M$42.0M$40.7M$38.1M$36.1M$31.9M

Cash Flow Statement

Annual (10-K / 20-F)

Metric \ Fiscal YearFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Financing Cash Flow *$16.4M$414.0K$31.3M$23.8M$7.9M$8.7M$81.8M$5.4M$86.4M$25.9M$15.6M
Investing Cash Flow *-$638.0K-$1.8M-$246.0K$0.00-$55.0K$32.9M-$3.8M$20.1M-$49.1M-$28.0K-$140.0K
Operating Cash Flow *-$24.7M-$18.1M-$13.4M-$10.7M-$13.1M-$27.1M-$79.2M-$51.1M-$22.7M-$13.9M-$9.1M
Share Based Compensation$4.5M$4.2M$4.9M$5.1M$3.6M$4.6M$4.8M$3.4M$1.3M$705.0K$427.0K
Increase Decrease In Prepaid Deferred Expense And Other Assets$51.0K$220.0K-$10.4M$10.9M-$1.9M$558.0K$505.0K$833.0K$487.0K$145.0K-$54.0K
Increase Decrease In Accounts Payable And Accrued Liabilities-$1.4M$614.0K$694.0K$681.0K-$631.0K-$5.6M-$314.0K$4.7M$1.4M$632.0K$1.1M
Proceeds From Stock Options Exercised$12.0K$33.0K$17.0K$388.0K$227.0K$7.0K$465.0K$239.0K$31.0K$14.0K$5.0K
Payments To Acquire Property Plant And Equipment$977.0K$1.8M$246.0K$0.00$55.0K$25.0K$88.0K$306.0K$3.0K$32.0K$140.0K
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans35.0K65.0K112.0K111.0K31.0K45.0K50.0K66.0K
Increase Decrease In Other Operating Capital Net$118.0K-$456.0K$83.0K$155.0K$140.0K$159.0K$55.0K-$92.0K
Proceeds From Issuance At The Market$2.5M$1.7M$566.0K$12.2M$12.0M$10.3M
Increase Decrease In Deferred Revenue-$75.0K-$130.0K$205.0K-$5.0M-$20.0K-$520.0K$500.0K$200.0K
Proceeds From Issuance Of Long Term Debt$0.00$0.00$991.0K$0.00$10.0M$7.9M$6.0M$3.0M
Proceeds From Sale And Maturity Of Available For Sale Securities$0.00$0.00$33.0M$76.5M$68.5M$5.7M
Increase Decrease In Deferred Rent-$76.0K$97.0K-$9.0K-$9.0K$9.0K
Increase Decrease In Other Operating Assets-$21.0K$5.0K-$882.0K-$1.8M$1.2M

Quarterly (10-Q, single quarters)

Metric \ QuarterQ1 2025Q1 2024Q1 2023Q1 2022Q1 2021Q1 2020Q1 2019Q1 2018Q1 2017Q1 2016
Financing Cash Flow *-$553.0K$14.3M$332.0K$65.0K$14.4M$1.2M$6.6M$79.0M$5.1M
Investing Cash Flow *-$9.0K-$57.0K-$115.0K$0.00$0.00-$55.0K$30.9M$12.2M-$6.0M
Operating Cash Flow *-$5.8M-$7.9M-$7.2M$3.9M-$5.6M-$2.8M-$12.7M-$15.7M-$11.0M-$4.4M
Share Based Compensation$721.0K$1.1M$1.0M$1.3M$1.2M$1.0M$1.2M$1.1M$752.0K$260.0K
Increase Decrease In Prepaid Deferred Expense And Other Assets$1.1M-$443.0K$165.0K-$10.7M-$279.0K-$49.0K-$1.5M$613.0K$2.3M-$119.0K
Increase Decrease In Accounts Payable And Accrued Liabilities$215.0K-$1.1M-$1.1M-$686.0K$1.3M-$1.1M-$14.0K$341.0K$872.0K$1.1M
Proceeds From Stock Options Exercised$0.00$12.0K$0.00$3.0K$38.0K$1.0K$237.0K$76.0K
Payments To Acquire Property Plant And Equipment$9.0K$57.0K$115.0K$0.00$55.0K$18.0K$309.0K
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans13.0K21.0K37.0K62.0K54.0K
Increase Decrease In Other Operating Capital Net$12.0K$488.0K$2.0K$39.0K$36.0K-$68.0K$29.0K
Proceeds From Issuance At The Market$434.0K$450.0K$295.0K$0.00$3.2M$1.2M$6.6M
Increase Decrease In Deferred Revenue$0.00$75.0K$75.0K$198.0K$0.00-$5.0K-$505.0K
Proceeds From Issuance Of Long Term Debt
Proceeds From Sale And Maturity Of Available For Sale Securities$31.0M$21.0M$7.0M
Increase Decrease In Deferred Rent-$26.0K-$10.0K$3.0K
Increase Decrease In Other Operating Assets-$12.0K$62.0K$6.0K

Per-Share & Share Counts

Annual (10-K / 20-F)

Metric \ Fiscal YearFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Diluted EPS *-$0.47-$0.53-$0.55$0.01-$0.39-$0.81-$2.69-$2.33-$1.97-$7.54-$5.86
Weighted Average Number Of Share Outstanding Basic And Diluted46.5M38.2M30.7M25.3M13.1M2.3M1.7M
Common Stock Shares Authorized200.0M200.0M100.0M100.0M100.0M100.0M100.0M100.0M40.0M
Common Stock Shares Outstanding62.9M60.6M59.7M51.9M44.4M32.1M25.4M24.6M2.7M
Common Stock Shares Issued62.9M60.6M59.7M51.9M44.4M32.1M25.4M24.6M2.7M
Common Stock Par Or Stated Value Per Share$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Preferred Stock Shares Issued0.000.000.000.000.000.000.000.000.00
Preferred Stock Shares Authorized10.0M10.0M10.0M10.0M10.0M10.0M10.0M10.0M0.00
Preferred Stock Par Or Stated Value Per Share$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Weighted Average Number Of Shares Outstanding Basic73.8M61.8M60.2M58.5M46.5M38.2M
Weighted Average Number Of Diluted Shares Outstanding73.8M61.8M60.2M59.9M46.5M38.2M
Earnings Per Share Basic$-0.47$-0.53$-0.55$0.01$-0.39

Quarterly (10-Q, single quarters)

Metric \ QuarterQ3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021Q1 2021Q3 2020Q2 2020Q1 2020Q4 2019Q3 2019Q2 2019Q1 2019Q4 2018Q3 2018Q2 2018Q1 2018Q4 2017Q3 2017Q2 2017Q1 2017Q4 2016Q3 2016Q2 2016Q1 2016Q4 2015Q3 2015Q2 2015Q1 2015
Diluted EPS *-$1.14-$0.06-$0.11-$1.54-$0.10-$0.17-$0.15-$0.15-$0.15-$0.13-$0.13-$0.13-$0.08-$0.11-$0.13-$0.05-$0.13-$0.07-$0.07-$0.17-$0.15-$0.45-$0.68-$0.75-$0.65-$0.62-$0.65-$0.72-$0.54-$0.41-$0.45-$0.28-$0.62-$2.05-$1.95-$1.31-$2.36-$2.07
Weighted Average Number Of Share Outstanding Basic And Diluted60.2M60.1M59.5M57.7M57.0M47.0M45.2M44.8M38.4M37.6M34.1M32.0M32.0M26.8M25.3M25.3M25.3M20.5M8.2M2.7M2.7M2.2M
Common Stock Shares Authorized26.7M400.0M200.0M13.3M200.0M200.0M200.0M200.0M200.0M200.0M200.0M100.0M100.0M100.0M100.0M100.0M100.0M100.0M100.0M100.0M100.0M100.0M100.0M100.0M100.0M100.0M100.0M100.0M100.0M
Common Stock Shares Outstanding5.2M78.5M77.3M5.1M74.7M74.7M74.7M62.1M61.7M61.4M60.2M60.2M60.1M59.6M59.1M57.6M48.2M46.3M44.9M41.1M37.7M36.8M32.0M32.0M31.9M25.3M25.3M25.3M20.5M19.6M
Common Stock Shares Issued5.2M78.5M77.3M5.1M74.7M74.7M74.7M62.1M61.7M61.4M60.2M60.2M60.1M59.6M59.1M57.6M48.2M46.3M44.9M41.1M37.7M36.8M32.0M32.0M31.9M25.3M25.3M25.3M20.5M19.6M
Common Stock Par Or Stated Value Per Share$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Preferred Stock Shares Issued0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Preferred Stock Shares Authorized10.0M10.0M10.0M10.0M10.0M10.0M10.0M10.0M10.0M10.0M10.0M10.0M10.0M10.0M10.0M10.0M10.0M10.0M10.0M10.0M10.0M10.0M10.0M10.0M10.0M10.0M10.0M10.0M10.0M10.0M
Preferred Stock Par Or Stated Value Per Share$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Weighted Average Number Of Shares Outstanding Basic5.2M77.8M76.9M5.0M74.7M69.9M62.0M61.7M61.2M60.2M60.2M60.1M59.5M
Weighted Average Number Of Diluted Shares Outstanding5.2M77.8M76.9M5.0M74.7M69.9M62.0M61.7M61.2M60.2M60.2M60.1M59.5M
Earnings Per Share Basic$-1.14$-0.06$-0.11$-1.54$-0.10$-0.17$-0.15$-0.15$-0.15$-0.13$-0.13$-0.13$-0.08

Other Metrics

Annual (10-K / 20-F)

Metric \ Fiscal YearFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value$4.5M$4.2M$4.9M$5.1M$3.6M$4.6M$4.8M$3.4M$1.3M$705.0K$427.0K
Depreciation$226.0K$67.0K$145.0K$178.0K$180.0K$211.0K$189.0K$182.0K$65.0K$60.0K$33.0K
Stock Issued During Period Value Stock Options Exercised$12.0K$33.0K$17.0K$388.0K$227.0K$7.0K$465.0K$239.0K$31.0K$14.0K$5.0K
Prepaid Expense Current$722.0K$704.0K$921.0K$722.0K$1.1M$2.0M$1.4M$396.0K$159.0K
Additional Paid In Capital$304.9M$299.0M$293.4M$264.6M$248.8M$230.5M$145.6M$136.9M$2.7M
Stock Issued During Period Value At Market Sales Agreement$2.5M$1.7M$566.0K$12.2M$12.0M$10.3M
Stock Issued During Period Value Employee Stock Purchase Plan$35.0K$65.0K$112.0K$111.0K$31.0K$45.0K$50.0K$66.0K
Paid In Kind Interest$0.00$0.00$59.0K$163.0K$154.0K$211.0K$283.0K$104.0K$82.0K

Quarterly (10-Q, single quarters)

Metric \ QuarterQ3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021Q1 2021Q3 2020Q2 2020Q1 2020Q3 2019Q2 2019Q1 2019Q3 2018Q2 2018Q1 2018Q3 2017Q2 2017Q1 2017Q3 2016Q2 2016Q1 2016
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value$746.0K$694.0K$721.0K$1.2M$1.1M$1.1M$1.1M$1.1M$1.0M$1.1M$1.4M$1.3M$1.3M$1.3M$1.2M$841.0K$891.0K$1.0M$970.0K$1.3M$1.2M$1.3M$1.2M$1.1M
Depreciation$85.0K$28.0K$15.0K$46.0K$45.0K$45.0K$53.0K$47.0K$30.0K$17.0K
Stock Issued During Period Value Stock Options Exercised$12.0K$23.0K$10.0K$4.0K$3.0K$149.0K$33.0K$38.0K$144.0K$72.0K$5.0K$15.0K$1.0K$196.0K$237.0K
Prepaid Expense Current$1.2M$1.6M$721.0K$734.0K$721.0K$364.0K$567.0K$1.1M$542.0K$762.0K$1.0M$439.0K$563.0K$1.2M$359.0K$410.0K$1.2M$595.0K$892.0K$1.5M$1.7M$497.0K$3.2M$2.4M$2.2M$712.0K$675.0K$2.5M$662.0K$737.0K
Additional Paid In Capital$319.9M$319.2M$317.5M$316.3M$313.1M$311.9M$310.8M$303.2M$301.8M$300.4M$297.3M$296.1M$294.8M$292.0M$288.6M$280.1M$256.8M$253.6M$251.0M$244.3M$240.9M$238.3M$229.3M$228.0M$226.6M$144.6M$143.7M$142.8M$102.5M$95.8M
Stock Issued During Period Value At Market Sales Agreement$977.0K$434.0K$450.0K$266.0K$362.0K$295.0K$1.9M$7.1M$3.2M$2.3M$1.6M$1.2M$2.4M$1.3M$6.6M
Stock Issued During Period Value Employee Stock Purchase Plan$10.0K$13.0K$14.0K$21.0K$28.0K$37.0K$51.0K$62.0K$57.0K$54.0K$31.0K$15.0K$45.0K
Paid In Kind Interest$10.0K$46.0K$49.0K$52.0K$38.0K

Most recent annual filing with the SEC: March 27, 2025

Data sourced from SEC EDGAR public filings as of August 5, 2026.